BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26137282)

  • 1. Association of the
    Wu L; Gao X; Ye D; Ding Y; Yang XI; Liu W
    Mol Clin Oncol; 2015 May; 3(3):649-654. PubMed ID: 26137282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
    Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
    Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis.
    He L; Deng T; Luo H
    Onco Targets Ther; 2015; 8():385-94. PubMed ID: 25709470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis on the association between xeroderma pigmentosum Group A A23G polymorphism and esophageal cancer in a Chinese population.
    Xu JL; Bai J; Jiao JF; Ding L; Lei L; Bai XP; Cheng YF
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1173-S1177. PubMed ID: 30539866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North Indians.
    Lawania S; Singh N; Behera D; Sharma S
    Biochem Genet; 2018 Aug; 56(4):375-396. PubMed ID: 29516319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between XPA gene rs1800975 polymorphism and susceptibility to lung cancer: a meta-analysis.
    Liu X; Lin Q; Fu C; Liu C; Zhu F; Liu Z; Li S; Jiang L
    Clin Respir J; 2018 Feb; 12(2):448-458. PubMed ID: 27460688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
    Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
    Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide excision repair pathway genes and oral premalignant lesions.
    Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
    Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPA A23G polymorphism and lung cancer risk: a meta-analysis.
    Zou JH; An L; Chen S; Ren LQ
    Mol Biol Rep; 2012 Feb; 39(2):1435-40. PubMed ID: 21611749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer.
    Park JY; Park SH; Choi JE; Lee SY; Jeon HS; Cha SI; Kim CH; Park JH; Kam S; Park RW; Kim IS; Jung TH
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):993-7. PubMed ID: 12376498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
    Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
    J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of human
    Yuan M; Yu C; Yu K
    Cancer Cell Int; 2020; 20():164. PubMed ID: 32435155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
    Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
    DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis.
    Jiang HY; Zeng Y; Xu WD; Liu C; Wang YJ; Wang YD; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(9):3645-51. PubMed ID: 25987016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies.
    Ding YW; Gao X; Ye DX; Liu W; Wu L; Sun HY
    Clin Transl Oncol; 2015 Sep; 17(9):710-9. PubMed ID: 26022132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls.
    Deng DL; Xia LY; He BY; Guo JM; Huang C; Zeng XT
    Med Sci Monit; 2015 Nov; 21():3514-20. PubMed ID: 26568042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis.
    Ding D; Zhang Y; Yu H; Guo Y; Jiang L; He X; Ma W; Zheng W
    Int J Cancer; 2012 Jul; 131(2):488-96. PubMed ID: 21866550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects.
    Yang XI; Zhu Y; Ye D; Liu Y; Sun H; Ruan M; Liu W
    Mol Clin Oncol; 2016 Jul; 5(1):175-180. PubMed ID: 27330794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
    Rafiq R; Bhat GA; Lone MM; Masood A; Dar NA
    Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.